Kerala Ayurveda Ltd. benchmarking: Perfomance to industry peers

Financial

	Kerala Ayurveda	Valiant Laboratories	Amanta Healthcare
Operational Metrics
Financials
5 yr Average ROE	-54.59 %	9.35 %	-40.92 %
5yr average Equity Multiplier	17.91	1.76	15.03
5yr Average Asset Turnover Ratio	0.77	0.81	0.64
5yr Avg Net Profit Margin	-3.82 %	2.4 %	3.09 %
Price to Book	75.3	1.23	1.89
P/E	0.0	77.21	37.98
5yr Avg Cash Conversion Cycle	-36.58 Days	75.62 Days	-22.38 Days
Inventory Days	51.76 Days	18.84 Days	95.39 Days
Days Receivable	51.0 Days	161.25 Days	65.27 Days
Days Payable	164.59 Days	82.33 Days	201.15 Days
5yr Average Interest Coverage Ratio	0.36	44.93	1.35
5yr Avg ROCE	0.83 %	7.68 %	13.45 %
5yr Avg Operating Profit Margin	3.63 %	0.79 %	21.61 %
5 yr average Debt to Equity	11.28	0.48	8.85
5yr CAGR Net Profit	24.88 %	n/a	n/a
5yr Average Return on Assets	-3.11 %	4.39 %	2.36 %
Shareholdings
Promoter Holding	33.14 %	74.94 %	63.56 %
Share Pledged by Promoters	23.56 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-28.38 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	-0.01 %	0.0	0.0

	Kerala Ayurveda	Valiant Laboratories	Amanta Healthcare
Product Wise Break-Up	Product Wise Break-Up Paracetamol 0 Product Partnering 0 International Branded Generics 0 Domestic Branded Generics 0 Others 100	Product Wise Break-Up International Branded Generics 0 Paracetamol 100.0 Domestic Branded Generics 0 Product Partnering 0	Product Wise Break-Up International Branded Generics 33.09 Paracetamol 0 Domestic Branded Generics 55.47 Product Partnering 10.5 Others 0.94